Journey Medical Stock
Journey Medical Corporation
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Claude Maraoui
- Employees
- 58
- Market cap
- $140 M
- IPO
- 12/11/2021
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological…
Journey Medical stock: price history
1D
-3.2%
1W
-21.3%
1M
-31.9%
6M
-7.9%
YTD
-35.6%
1Y
-32.9%
2Y
-20.9%
5Y
–
10Y
–
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~49% stronger price swings than usual
Ask the agents about Journey Medical
Analyst assessment of Journey Medical
PRICE TARGET LOW
US$10.50
CONSENSUS
US$11.75
MEDIAN
US$11.75
PRICE TARGET HIGH
US$13.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 13/08/2026
Journey Medical stock metrics
P/E
-21.98
P/B
4.25
EV/EBITDA
74.84
RETURN ON EQUITY
-1.0%
NET MARGIN
-1.7%
DEBT/EQUITY
0.8
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
51.5%
FLOAT SHARES
14,534,377
AVG. DAILY VOLUME (30D)
187,588
Insider transactions (SEC)
Herskowitz Neil
Smith Justin Adam
Toledano Miranda Jayne
Toledano Miranda Jayne
ROSENWALD LINDSAY A MD
Institutional holders
Comparable stocks
Frequently asked questions about Journey Medical stock
What does Journey Medical do?
Journey Medical Corporation is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Claude Maraoui, the company employs around 58 people.
The IPO was on 12/11/2021; the stock trades on NASDAQ under the ticker DERM.
What do analysts say about Journey Medical stock?
3 analysts rate the stock, the consensus is Buy (as of 13/08/2026).
The average price target is US$11.75, ranging from US$10.50 to US$13.00, with a median of US$11.75.
This is an external assessment, not a statement by Market Jury.
When does Journey Medical report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 49% stronger than usual.
Does Journey Medical pay a dividend?
No, Journey Medical currently does not pay a dividend.
Which stocks are comparable to Journey Medical?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Journey Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Journey Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.